Kingswood Capital Management in several transactions, including:
- Financing related to its acquisition of Daramic, a global leader in high-performance polyethylene battery separators.
- Financing of Drive Medical’s purchase of the assets of Compass Health, a diversified supplier of branded and private label consumer medical products.
- Financing of its acquisition of Soulshine Farms, a major provider of poultry further-processing solutions.
ASP Unifrax Holdings, Inc. (Alkegen) and 62 of its affiliates in debtor-in-possession (DIP) and exit financing for the company’s Chapter 11 cases in the U.S. Bankruptcy Court for the Northern District of Texas. Alkegen is a global manufacturer of high-performance thermal management, filtration and battery fire protection solutions under a variety of product families. Alkegen commenced Chapter 11 to implement a comprehensive prepackaged restructuring designed to de-lever its balance sheet by $3.1 billion of its approximately $3.4 billion of funded debt obligations.
Pretium Packaging, L.L.C. (Pretium) and nine of its affiliates in debtor-in-possession (DIP) and exit financing for the company’s voluntary prepackaged Chapter 11 proceedings in the U.S. Bankruptcy Court for the District of New Jersey. Pretium entered into Chapter 11 to implement a comprehensive restructuring transaction that eliminated over $900 million of the company’s approximately $1.8 billion funded debt obligations with the overwhelming support of existing lenders and Clearlake Capital Partners, Pretium’s equity sponsor. Pretium received approval for up to $533.5 million in DIP term loans and access to a $100 million DIP ABL facility and, upon confirmation of the plan, such DIP facilities rolled to exit financing to support Pretium’s long-term growth.
General Catalyst and Health Assurance Transformation Company in working capital financing related to the acquisition of Summa Health.
